Pharma-Tone Profile
Key Indicators
- Authorised Capital ₹ 0.45 M
as on 11-12-2024
- Paid Up Capital ₹ 0.25 M
as on 11-12-2024
- Company Age 61 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 10.24%
(FY 2023)
- Profit -99.94%
(FY 2023)
- Ebitda -109.70%
(FY 2023)
- Net Worth 0.13%
(FY 2023)
- Total Assets 50.37%
(FY 2023)
About Pharma-Tone
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.45 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Patel, Rajesh Patel, Bhavna Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH1963PTC012608
- Company No.
012608
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 1963
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Pharma-Tone Private Limited offer?
Pharma-Tone Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Anti Allergic Drug, Common Disease Medicines, Skin Lightening Drugs, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Anesthetic.
Who are the key members and board of directors at Pharma-Tone?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Patel  | Director | 21-Nov-1978 | Current |
| Rajesh Patel | Director | 01-Apr-2008 | Current |
| Bhavna Patel | Director | 23-Nov-2020 | Current |
| Priya Patel | Director | 23-Nov-2020 | Current |
Financial Performance of Pharma-Tone.
Pharma-Tone Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.24% increase. The company also saw a substantial fall in profitability, with a 99.94% decrease in profit. The company's net worth moved up by a moderate rise of 0.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma-Tone?
Unlock access to Pharma-Tone's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharma-Tone?
Unlock and access historical data on people associated with Pharma-Tone, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma-Tone, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma-Tone's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
